Physicians put patients at risk by underestimating the risk of stroke and overestimating the risk of bleeding. Hear the experts' take on removing the fear from novel oral anticoagulant therapy and listen to them discuss why it is irrational to overestimate the relative risk of bleeding with anticoagulant therapy.
Many physicians shy away from novel oral anticoagulants because they do not have a reversal agent. Little do they know, say the experts, that warfarin doesn’t either. And the best way to stop bleeding is to prevent it in the first place. In this segment, the panelists discuss these topics, as well as how to properly stop anticoagulation when necessary.
Study results indicate that low-field magnetic stimulation synchronized to an individual's alpha frequency—dubbed "synchronized transcranial magnetic stimulation"—appears to be safe, effective, and well tolerated for treating major depressive disorder when properly administered.
Study results suggest that brain inflammation resulting from chronic nerve pain appears to alter activity in brain regions that regulate mood and motivation. The findings indicate, for the first time, a direct biophysical relationship between long-term pain and the co-morbid anxiety, depression, and substance abuse observed in more than 50% of patients with chronic nerve pain.